ENCell: Clinical Trials

2 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 5 Phase 1, 3 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	5	Completed 2, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 2	3	Not yet recruiting 1, Recruiting 1, Unknown 1

Follow ENCell: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia EN001, EN001 Placebo - Sarcopenia	Phase 1 / Phase 2	Not yet recruiting	ENCell	132	2027-03-01	2026-09-11
Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter) EN001, EN001 Placebo - Charcot-Marie-Tooth Disease Type 1A	Phase 1 / Phase 2	Recruiting	ENCell	27	2024-05-30	2026-05-26
Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy EN001 - Duchenne Muscular Dystrophy	Phase 1 / Phase 2	Unknown	ENCell	88	2024-03-01	2024-03-25
Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A EN001 - Charcot-Marie-Tooth Disease, Type IA	Phase 1	Completed	ENCell	9	2022-02-22	2023-02-17
Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD) EN001 - Duchenne Muscular Dystrophy	Phase 1	Completed	ENCell	7	2022-01-18	2024-08-30

Conditions studied

Charcot-Marie-Tooth Disease (2)  ·  Muscular Dystrophy, Duchenne (2)  ·  Sarcopenia (1)

Countries

South Korea (5)